Kansas City Proton Institute Powered by KCUC

Story by Jeanie Edgmon

Revolutionizing Cancer Care: Inside the Kansas City Proton Institute

The word “cancer” is one of the most concerning, fearful, and isolating words in our language. The Kansas City Proton Institute (KCPI) team powered by KCUC aims to change that by blending cutting-edge technology delivered in a more comfortable office setting.

As the newest addition to the United States’ roster of proton therapy centers, and uniquely distinguished as the only non-hospital-based facility of its kind in the central U.S., KCPI represents a significant leap forward in the fight against cancer. Opening its doors in October 2023, this 34,000-square-foot center has quickly positioned itself as one of the most sought-after destinations for cancer care, underscoring the demand for more advanced and patient-centered treatment options.

An Unparalleled Team of Experts

The foundation of KCPI’s success lies in its team of dedicated professionals. With three radiation oncologists including, Kenon Qamar, MD, James Coster, MD, and Mark Thompson, MD, and two medical oncologists specializing in urology cancers, Sukumar Ethirajan, MD, and Jaswinder Singh, MD the institute boasts a wealth of experience and expertise. Each physician at KCPI has been recognized for their contributions to the field, with over 25 years of experience in treating a wide range of cancer types. This collective expertise ensures that every treatment plan is informed by decades of clinical experience and the latest in oncological research.

A Beacon of Hope and Innovation

KCPI is not just a medical facility; it’s a beacon of hope for patients, offering access to the latest in proton radiotherapy, photon (x-ray) radiotherapy, a dedicated PET scanner, and a comprehensive radiopharmaceutical administration program. This suite of cutting-edge technology enables the delivery of precise treatment options tailored to the needs of each patient, setting a new standard in cancer care.

However, the doctors and staff understand that quality care is not just about technology.

“While we place a high priority on the technologies we employ, we place just as much emphasis on providing personal and compassionate care,” explains James Coster, MD. “We understand this is a scary and monumental time in an individual’s life and just as concerning for their loved ones. We do everything we can to support the well-being of our patients.”

The Power of Proton Therapy

At the heart of KCPI’s treatment offerings is proton therapy, a form of radiation therapy that allows for precise targeting of tumors with minimal impact on surrounding healthy tissues. This precision is critical in the treatment of cancers located near vital organs or in sensitive areas, where traditional radiation therapy’s broader impact can lead to significant side effects. Proton therapy’s ability to localize radiation dose more effectively translates into better outcomes for patients, with reduced side effects and improved quality of life during and after treatment.

“Proton therapy is generally painless, and patients can resume normal daily activities afterward. The fact that we deliver it in an office setting also helps reduce stress which improves the overall experience,” shared Mark Thompson, MD.

A Commitment to Compassionate Care

Beyond its technological and medical prowess, KCPI is deeply committed to providing compassionate care. Recognizing the immense emotional and physical toll of cancer diagnosis and treatment, the institute places a strong emphasis on supporting patients’ emotional well-being alongside their physical health. This holistic approach to care is a cornerstone of KCPI’s philosophy, ensuring that patients and their families are supported through every step of their treatment journey.

Convenience, Accessibility, And Affordability

“If the cost was not a barrier, most patients would choose proton therapy for localized tumors,” explained Kenon Qamar, MD. “Until very recently, most hospitals were not able to offer the treatment because the equipment required a massive space and financial commitment. Now, with the advancement in proton therapy technology, the systems are much smaller and much less costly to build and operate. This makes the treatment far more accessible and affordable for patients.”

KCPI’s non-hospital-based setting offers an unprecedented level of convenience and accessibility for patients. Without the need to navigate complex hospital layouts, parking garages, and the associated stress of hospital visits, patients can access their treatments with ease. This focus on patient convenience is reflective of KCPI’s overall approach to care, where every aspect of the patient experience is designed to reduce stress and facilitate healing.

Leading the Way in Clinical Research

As a member of the Proton Collaborative Group (PCG), KCPI plays a vital role in advancing the field of proton therapy through clinical research. Participation in large-scale clinical trials and access to the world’s most comprehensive proton therapy database enable KCPI to contribute to the global body of knowledge on proton therapy’s effectiveness and applications. This commitment to research not only enhances the care provided at KCPI but also contributes to the ongoing improvement of cancer treatment protocols worldwide.

The Future of Oncology

The development of proton therapy from an experimental treatment to a standard care option marks a significant evolution in cancer treatment. With its advantages over traditional radiation therapy, including reduced side effects and the potential for more aggressive targeting of tumors, proton therapy is poised to play an increasingly important role in oncology. KCPI’s leadership in this area underscores the institute’s commitment to providing the most advanced and effective treatment options to its patients.

“While the use of proton therapy is becoming more prevalent, the gap between the number of patients who receive it versus those that can benefit is still significant. Our goal is to narrow that gap as much as possible in our area,” furthered Kenon Qamar, MD.

Why Choose KCPI for Cancer Care?

Choosing where to receive cancer treatment is a critical decision for patients and their families. KCPI distinguishes itself through its cutting-edge technology, expert medical team, and unwavering commitment to patient care. The institute’s unique combination of advanced treatment options, compassionate care, and convenient, stress-free access makes it a premier destination for those seeking the best in cancer treatment.

Patients at KCPI benefit from personalized treatment plans that leverage the latest in medical research and technology, delivered by a team of physicians recognized for their expertise and dedication to patient care. The institute’s holistic approach, which values patients’ emotional and physical well-being equally, ensures a supportive and nurturing environment throughout the treatment process.

A Vision for the Future

The Kansas City Proton Institute is more than just a medical facility; it’s a center of hope, innovation, and compassion. As the newest and only non-hospital-based proton therapy center in the central United States, KCPI is at the forefront of a new era in cancer treatment. With its state-of-the-art technology, dedicated team of professionals, and commitment to patient-centered care, KCPI is changing the landscape of cancer treatment and setting new standards for patient care and quality of life during and after treatment.

The Kansas City Proton Institute represents the pinnacle of modern oncology care. Its innovative approach to treatment, combined with a deep commitment to patient well-being, makes it a model for future cancer treatment centers worldwide. As KCPI continues to grow and evolve, its impact on the lives of those it serves will undoubtedly continue to expand, offering new hope and possibilities to patients facing the challenge of cancer.

For more information on Kansas City Proton Institute

please call (913) 456-5274 or visit their site https://kansascityprotoninstitute.com/